Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Infinity Pharmaceuticals (NQ: INFI )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 13, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Infinity Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 Next >
Infinity Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Infinity Pharmaceuticals Provides MARIO-3 Update in Patients with Front Line Metastatic Triple Negative Breast Cancer Suggesting Potential Long-Term Patient Benefit of Eganelisib
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Infinity Pharmaceuticals Announces the Date of Its Third Quarter 2022 Financial Results Conference Call and Webcast
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday
Gainers 
Via Benzinga
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids. 
Via Benzinga
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
  
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
  
Via Benzinga
11 Health Care Stocks Moving In Wednesday's Pre-Market Session
  Gainers   
Via Benzinga
Infinity Pharmaceuticals: Q2 Earnings Insights
  Infinity Pharmaceuticals (NASDAQ:INFI) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
  
Via Benzinga
Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday's Mid-Day Session
Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380. 
Via Benzinga
Infinity Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Infinity Pharmaceuticals Announces the Date of Its Second Quarter 2022 Financial Results Conference Call and Webcast
From Infinity Pharmaceuticals, Inc.
Via Business Wire
70 Biggest Movers From Friday
Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for... 
Via Benzinga
81 Biggest Movers From Yesterday
Gainers Eos Energy Enterprises, Inc. (NASDAQ: EOSE) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises recently reported worse-than-expected Q1 EPS and sales results. 
Via Benzinga
Infinity Pharmaceuticals to Participate in Upcoming H.C. Wainwright Global Investment Conference
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Infinity Pharmaceuticals's Return On Capital Employed Insights
Benzinga Pro data, Infinity Pharmaceuticals (NASDAQ:INFI) reported Q1 sales of $652.00 thousand. Earnings fell to a loss of $12.44 million, resulting in a 6.74% decrease from last quarter. 
Via Benzinga
Infinity Pharmaceuticals: Q1 Earnings Insights
Infinity Pharmaceuticals (NASDAQ:INFI) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Infinity Pharmaceuticals Reports First Quarter 2022 Financial Results
From Infinity Pharmaceuticals, Inc.
Via Business Wire
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
99 Biggest Movers From Yesterday
Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company. 
Via Benzinga
Infinity Pharmaceuticals Earnings Preview
Infinity Pharmaceuticals (NASDAQ:INFI) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Infinity Pharmaceuticals Announces the Date of Its First Quarter 2022 Financial Results Conference Call and Webcast
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Infinity Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Infinity Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Adagio Therapeutics (NASDAQ:ADGI) shares rose 40.0% to $5.39 during Wednesday's regular session. Trading volume for this security as of 13:31 EST is 80.0... 
Via Benzinga
51 Biggest Movers From Yesterday
Gainers Forge Global Holdings, Inc. (NYSE: FRGE) jumped 73.9% to close at $37.64. Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 60.5% to close at $4.14 on Wednesday... 
Via Benzinga
Infinity Pharmaceuticals Earnings Perspective: Return On Capital Employed
Infinity Pharmaceuticals (NASDAQ:INFI) brought in sales totaling $451.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 8.76%, resulting in a loss of $11.65... 
Via Benzinga
Infinity Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Company Highlights
From Infinity Pharmaceuticals, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.